VBC Market / Companies
Expert articles and analysis related to vbc market / companies.
AI Summary — Last 30 Days
Recent expert discussion on VBC Market / Companies. See linked articles for details.
Related Articles
Hospital M&A rebounds after 2025 lull
Mergers and acquisitions in the first quarter hit multi-year highs after providers pumped the brakes last year on deal-making due to financial stress and policy uncertainty from Washington, according ...
General Atlantic Acquires Home Care Provider TEAM Services For $3B
The unconventional players in the physician acquisition game
As independent practices buckle under rising costs, administrative burdens and stagnant reimbursement, a new and unlikely cast of acquirers has entered the game, moving beyond the traditional hospital...
ICYMI: Ocasio-Cortez Calls Out CVS Health’s Corporate Strategy to Monopolize Patient Care | Representative Ocasio-Cortez
From newsletter: The LI Daily: The thirst for insurance trustbusting The thirst for insurance trustbusting AXIOS Caitlin Owens April 03, 2026 Illustration: Brendan Lynch/Axios. Stock: Getty Images T...
Q&A: WestBridge Capital on AI-driven consolidation of power, startup survival
Kamal Singh, senior vice president at global investment firm WestBridge Capital, sat down with MobiHealthNews to discuss the potential for consolidation of power among select companies due to AI's imp...
22 deals, $14.5B transacted revenue: What robust Q1 hospital M&A signals
22 deals, $14.5B transacted revenue: What robust Q1 hospital M&A signals Becker's Hospital Review
Orlando Health agrees to acquire Alabama-based RMC Health System
The deal, which the health systems expect to close in the fall, will further expand Orlando Health’s presence in the state after it acquired Birmingham-based Baptist Health in 2024.
Digital health funding concentrates in fewer startups: report
Companies raised $4 billion in the first quarter, an increase of $1 billion over the prior year, according to Rock Health. But nearly 60% of the capital deployed came from 12 large deals.
STAT+: Gilead to buy cancer biotech Tubulis for more than $3 billion
Gilead is buying the German biotech Tubulis for more than $3 billion, a move that will expand its oncology pipeline.
Three-quarters of AI’s economic gains are being captured by just 20% of companies – with the leading companies focused on growth, not just productivity
Three-quarters of AI’s economic gains are being captured by just 20% of companies – with the leading companies focused on growth, not just productivity PwC